![Citeline Podcasts artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/0f/4f/ef/0f4fef8f-28fc-8de1-8d89-184cfda23e39/mza_5528053617673757912.jpg/100x100bb.jpg)
Pink Sheet Podcast: FDA User Fees, Real-Time Oncology Review, ALS Accelerated Approval, Opioid Suit
Citeline Podcasts
English - July 29, 2022 15:29 - 6 minutes - 4.06 MB - ★★★★★ - 24 ratingsBusiness News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Gennova CEO Singh On India’s mRNA Vaccine, Using Tech Against Cancer, Potential Equity Partnering
Next Episode: Scrip’s Five Must-Know Things – 1 August 2022
Pink Sheet reporter looks at the biggest US FDA and pharma industry stories of the week, including the status of US FDA user fee renewal legislation, new real-time oncology review program guidance, Biogen’s ALS accelerated approval play, and Teva settling opioid litigation.